Dr. Roy S. Herbst
100% to Research

100% to Research

Your donation will have an immediate impact on the fight against cancer.

Learn More

On October 11, 2006, Jeff Wigbels learned he had Stage IV non-smokers lung cancer. The next day, his wife — unaware of this — gave birth to their son. The following day, Jeff told her there was a good chance their son soon might not have a dad. But today, because of the targeted therapy being developed at M. D. Anderson, Jeff is watching his children grow up. He believes he’s been given a gift, one that he and Tiffany want to give back.

Learn more about Jeff, the molecular-level cancer research and treatment that’s helped him beat the odds and the Take Aim at Cancer Research Fund.

Donate now to support targeted-therapy cancer research and treatment.

Survivor Wine - Prepare to toast to your health.

Researching and advancing molecular-level cancer therapy for promising results.

LUNGevity YouTube LUNGevity Facebook LUNGevity Twitter